Utility of pre- and post-pembrolizumab (Pembro) Vesical Imaging-Reporting and Data System (VIRADS) to predict the pathological response in muscle-invasive urothelial bladder cancer (MIBC): An analysis of the PURE-01 cohort.

Brembilla, G; Basile, G; Bandini, M; Raggi, D; Marandino, L; de Padua, TC; Patanè, DA; Crupi, E; Del Prete, A; Colombo, R; Colecchia, M; Lucianò, R; Moschini, M; Ross, JS; Briganti, A; Montorsi, F; De Cobelli, F; Necchi, A

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 ():